title: Using acellular pertussis vaccines for childhood immunization. Potential benefits far outweigh potential risks.
abstract: If acellular vaccines can offer protection against pertussis that is similar to that afforded by whole-cell vaccines and do so with reduced adverse effects, why have these agents not completely replaced the whole-cell preparations? This article provides an overview of general characteristics of both types of vaccine and some concerns and issues that remain in many physicians' minds. In addition, the authors furnish a rationale and recommendations for safe and appropriate use of the newer acellular formulations.
authors.affiliation: Department of Pediatrics, University of Texas Health Science Center at San Antonio 78284-7811, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Conrad
authors.forename: H B
authors.initials: HB
authors.lastname: Jenson
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000009:adverse effects; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D014481:United States / Q000453:epidemiology; D014917:Whooping Cough / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines